openPR Logo
Press release

Immunoglobulin Market Size to Reach USD 25.8 Billion by 2033 | With a 4.70% CAGR

12-06-2024 10:15 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: IMARC Group

Immunoglobulin Market

Immunoglobulin Market

๐†๐ฅ๐จ๐›๐š๐ฅย ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐งย ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ญ๐š๐ญ๐ข๐ฌ๐ญ๐ข๐œ๐ฌ: ๐”๐’๐ƒ ๐Ÿ๐Ÿ“.๐Ÿ– ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐•๐š๐ฅ๐ฎ๐ž ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ‘

๐’๐ฎ๐ฆ๐ฆ๐š๐ซ๐ฒ:

โ— The global immunoglobulin market size reached USD 16.5 Billion in 2024.
โ— The market is expected to reach USD 25.8 Billion by 2033, exhibiting a growth rate (CAGR) of 4.70% during 2025-2033.
โ— North America leads the market, accounting for the largestย immunoglobulin industry share.
โ— IgG accounts for the majority of the market share in the product segment due to IgG's effectiveness and safety profile.
โ— Immunodeficiency disease holds the largest share in the immunoglobulin industry.
โ— Intravenous mode of delivery remains a dominant segment in the market owing to the established protocols and healthcare infrastructure for intravenous administration.
โ— The rising prevalence of immunodeficiency diseases is a primary driver of the immunoglobulin market.
โ— The increasing Awareness and diagnosis of immunodeficiency diseases is reshaping the immunoglobulin market.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐š ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐œ๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/immunoglobulin-market/requestsample

๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ ๐š๐ง๐ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ:

โ— ๐‘๐ข๐ฌ๐ข๐ง๐  ๐ฉ๐ซ๐ž๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐๐ž๐Ÿ๐ข๐œ๐ข๐ž๐ง๐œ๐ฒ ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž๐ฌ:

For this reason, when the general prevalence of PIDDs and SID rises in any society, there is always a demand for immunoglobulin therapies for the diseases. However in any occasion there is an immune system disease, immunoglobulin therapies are essential because it is helpful to bring along antibodies which are an important culprit in fighting diseases. This leads to frequent application of immunoglobulin products since it is used in such basic functions as prevention of occurrence of diseases in a more permanent basis. Other advancement in this area is increase in the identification and analysation of diagnosis procedures increase early detection of immunodeficiency diseases. This leads to first-line treatment of potential disease expressions with immunoglobulin products, thereby fortifying the stoke of product market demand. A vast majority of immunodeficiency patients need intravenous immunoglobulin in their entire lifetime, therefore guaranteeing stable high market prospects in the future. This makes them to always generate revenued because it is a chronic treatment factor.

โ— ๐€๐ ๐ข๐ง๐  ๐๐จ๐ฉ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง:

For instance the health of elderly population has been worsened through bad immune system mechanisms whereby the elderly get diseases and recurring diseases. The demographic particularly needs more immunoglobulin therapies because the treatment helped in enhancing its immunity. This group of people also has pre dispositions to various ailments and conditions that are rife with old age such as diabetic conditions, cardiac conditions, auto immune diseases among others. Administration of immunoglobulin is more in complication from these diseases hence; there is rising use of immunoglobulin. Many diseases that are widespread among older populations: Immunoglobulin is required in cases of Alzheimer's disease, Parkinson's disease, malignant tumors and so on. This population usually requires chronic diseases for which, in most cases, immunoglobulin treatment is necessary. The fact that immunoglobulin products require constant maintenance treatment is advantageous because it establishes a more stable and hence easier to manage business.

โ— ๐ˆ๐ง๐œ๐ซ๐ž๐š๐ฌ๐ข๐ง๐  ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐š๐ง๐ ๐๐ข๐š๐ ๐ง๐จ๐ฌ๐ข๐ฌ:

Immunodeficiency diseases are more familiar to doctors and the public, and therefore are diagnosed at an earlier stage. Early intervention with immunoglobulin therapies is essential and demanded. Increased assistance seeking by informed patients raises both diagnoses, and therefore the size of the treatment group. Dental doctors have received training throughout the years as an effort to correctly diagnose their patient and come out with better treatment thus increasing the prescription for therapy. Many immunodeficiency disorders have become easily diagnosed using the latest diagnostic tools, and thus more patients are being treated.

๐๐ฎ๐ฒ ๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/checkout?id=4505&method=502

๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐œ๐ญ:

โ— IgG
โ— IgA
โ— IgM
โ— IgE
โ— IgD

IgG represents the largest segment as IgG is the most abundant immunoglobulin in human serum and is widely used for various therapeutic applications.

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง:

โ— Hypogammaglobulinemia
โ— Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
โ— Immunodeficiency Disease
โ— Myasthenia Gravis
โ— Others

Immunodeficiency disease accounts for the majority of the market share. Immunodeficiency diseases require ongoing treatment with immunoglobulin therapies, resulting in a substantial demand that accounts for a significant portion of market share.

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐Œ๐จ๐๐ž ๐จ๐Ÿ ๐ƒ๐ž๐ฅ๐ข๐ฏ๐ž๐ซ๐ฒ:

โ— Intravenous Mode of Delivery
โ— Subcutaneous Mode of Delivery

Intravenous mode of delivery exhibits a clear dominance in the market due to its rapid administration and higher plasma levels of immunoglobulin, making it the preferred method for many clinicians and patients.

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง:

โ— North America (United States, Canada)
โ— Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
โ— Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
โ— Latin America (Brazil, Mexico, Others)
โ— Middle East and Africa

North America enjoys the leading position in the immunoglobulin market on account of its well-established healthcare infrastructure, higher prevalence of immunodeficiency diseases, and greater access to advanced treatment options.

๐€๐ฌ๐ค ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/request?type=report&id=4505&flag=C

๐“๐จ๐ฉย ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐›๐ฎ๐ฅ๐ข๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‹๐ž๐š๐๐ž๐ซ๐ฌ:

The immunoglobulin market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

โ— ADMA Biologics Inc.
โ— Baxter international Inc.
โ— Biotest AG
โ— CSL Limited
โ— Grifols S.A
โ— Kedrion S.p.A
โ— LFB SA
โ— Octapharma AG
โ— Sanquin Plasma Products B.V.
โ— Takeda Pharmaceutical Company Limited

๐๐จ๐ญ๐ž: ๐ˆ๐Ÿ ๐ฒ๐จ๐ฎ ๐ซ๐ž๐ช๐ฎ๐ข๐ซ๐ž ๐š๐ง๐ฒ ๐ฌ๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐ญ๐ก๐š๐ญ ๐ข๐ฌ ๐ง๐จ๐ญ ๐œ๐จ๐ฏ๐ž๐ซ๐ž๐ ๐œ๐ฎ๐ซ๐ซ๐ž๐ง๐ญ๐ฅ๐ฒ ๐ฐ๐ข๐ญ๐ก๐ข๐ง ๐ญ๐ก๐ž ๐ฌ๐œ๐จ๐ฉ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ฐ๐ž ๐ฐ๐ข๐ฅ๐ฅ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ž ๐š๐ฌ ๐š ๐ฉ๐š๐ซ๐ญ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunoglobulin Market Size to Reach USD 25.8 Billion by 2033 | With a 4.70% CAGR here

News-ID: 3775697 • Views: โ€ฆ

More Releases from IMARC Group

IT Outsourcing Market Size, Share, Trends And Growth Report 2025-2033
IT Outsourcing Market Size, Share, Trends And Growth Report 2025-2033
Overview IT Outsourcing Market: The IT Outsourcing Market is rapidly evolving, driven by the need for cost efficiency and access to specialized skills. Companies increasingly outsource IT functions such as application development, infrastructure management, and business process outsourcing to third-party vendors. This trend allows organizations to focus on core competencies while leveraging advanced technologies. Key regions include North America, Europe, and Asia-Pacific, with North America leading due to its robust ITโ€ฆ
Urban EV Shift Drives India Electric Scooter Market to USD 3.0 Billion by 2033, Growing at 9.60% CAGR
Urban EV Shift Drives India Electric Scooter Market to USD 3.0 Billion by 2033, โ€ฆ
India Electric Scooter Market 2025-2033 According to IMARC Group's report titled "India Electric Scooter Market Size, Share, Trends and Forecast by Drive, Battery, Product, Battery Fitting, End Use, and Region, 2025-2033", The report offers a comprehensive analysis of the industry, including India electric scooter market growth, share, trends, and regional insights. How Big is the India Electric Scooter Industry? The India electric scooter market size was valued USD 1.3 Billion in 2024. Byโ€ฆ
Rising Cyber Threats Push India Cyber Insurance Market to USD 6,907.8 Million by 2033; Growing at 29.26% CAGR
Rising Cyber Threats Push India Cyber Insurance Market to USD 6,907.8 Million by โ€ฆ
India Cyber Insurance Market 2025-2033 According to IMARC Group's report titled "India Cyber Insurance Market Size, Share, Trends and Forecast by Component, Insurance Type, Organization Size, End Use Industry, and Region, 2025-2033", The report offers a comprehensive analysis of the industry, including India cyber insurance market forecast, share, growth and regional insights. Market Size & Future Growth Potential: The cyber insurance market in india was valued USD 582.2 Million in 2024. By 2033,โ€ฆ
Human Resource (HR) Technology Market Size, Share, Trends and Forecast 2025-2033
Human Resource (HR) Technology Market Size, Share, Trends and Forecast 2025-2033
Human Resource Technology Market Overview: The human resource (HR) technology market is witnessing significant growth, driven by increasing digital transformation across organizations and the rising need for automation in workforce management. HR technology solutions, including talent acquisition platforms, payroll systems, performance management software, employee engagement tools, and learning & development platforms, are becoming integral to modern businesses. Cloud adoption, AI-powered analytics, and the shift toward remote and hybrid work models haveโ€ฆ

All 5 Releases


More Releases for Immunoglobulin

Immunoglobulin Market Forecast 2035 | Advancing Therapeutic Outcomes: Growth of โ€ฆ
An extensive study of propelling opportunities in, "Immunoglobulin Market Size, Share & Trends Analysis Report by Product Type (IgG, IgA, IgM, IgE, IgD), Form, Route of Administration, Application, Source, Technology, Therapy Type, Patient Demographics, End-user / Distribution Channel and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A comprehensive report of growing market landscapes in the immunoglobulin sectorโ€ฆ
Rabies Immunoglobulin Market - Dynamics and Growth Pattern
The "Rabies Immunoglobulin Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. Rabies Immunoglobulin Market report offers an in-depth analysis on segments including top companies, products, applications, revenue and regions. a number of topics including likewise market share, drivers, trends and methods. This report additionally offers insights into the latest growth and trends. It encapsulates key aspects of the market, with focus on leadingโ€ฆ
Key Subcutaneous Immunoglobulin (SCIG) Market Trend for 2025-2034: Advancements โ€ฆ
What Is the Future Outlook for the Subcutaneous Immunoglobulin (SCIG) Market's Size and Growth Rate? There has been a rapid expansion in the subcutaneous immunoglobulin (SCIG) market size in the previous years. It's projected to swell from $12.72 billion in 2024 to $14.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.1%. The upsurge in the past era is credited to the heightened occurrence of immunodeficiency disorders,โ€ฆ
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t โ€ฆ
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market .It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, Southโ€ฆ
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t โ€ฆ
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China,โ€ฆ
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) ofโ€ฆ